
Larkai Healthcare, founded in 2020, leverages cutting-edge AI technologies to bridge the gap between diagnosis and treatment. Their innovative products, including the Wren multiparameter monitor and Cardiomate, enable real-time monitoring and early detection of cardiopulmonary anomalies, significantly reducing diagnosis times. With a focus on accessibility and affordability, Larkai aims to enhance healthcare delivery globally, positioning itself as a leader in the medtech space. The company has received multiple awards for its innovations, indicating strong traction and recognition in the market.

Larkai Healthcare, founded in 2020, leverages cutting-edge AI technologies to bridge the gap between diagnosis and treatment. Their innovative products, including the Wren multiparameter monitor and Cardiomate, enable real-time monitoring and early detection of cardiopulmonary anomalies, significantly reducing diagnosis times. With a focus on accessibility and affordability, Larkai aims to enhance healthcare delivery globally, positioning itself as a leader in the medtech space. The company has received multiple awards for its innovations, indicating strong traction and recognition in the market.